These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23989787)

  • 1. An audience with... Tachi Yamada. Interviewed by Asher Mullard.
    Yamada T
    Nat Rev Drug Discov; 2013 Sep; 12(9):658-9. PubMed ID: 23989787
    [No Abstract]   [Full Text] [Related]  

  • 2. An audience with...Francis Collins. Interviewed by Asher Mullard.
    Collins F
    Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031
    [No Abstract]   [Full Text] [Related]  

  • 3. An audience with Guido Rasi. Interview by Asher Mullard.
    Rasi G
    Nat Rev Drug Discov; 2012 Mar; 11(3):182. PubMed ID: 22378260
    [No Abstract]   [Full Text] [Related]  

  • 4. Jane Reese-Coulbourne. Interviewed by Asher Mullard.
    Reese-Coulbourne J
    Nat Rev Drug Discov; 2012 Aug; 11(8):594. PubMed ID: 22850775
    [No Abstract]   [Full Text] [Related]  

  • 5. Tadataka Yamada: new leader in global health.
    McCarthy M
    Lancet; 2006 Aug; 368(9535):573. PubMed ID: 16905008
    [No Abstract]   [Full Text] [Related]  

  • 6. RuiPing Dong. Interview by Asher Mullard.
    Dong R
    Nat Rev Drug Discov; 2012 Feb; 11(2):100. PubMed ID: 22293559
    [No Abstract]   [Full Text] [Related]  

  • 7. An audience with… Henry Chesbrough. Interview by Asher Mullard.
    Chesbrough H
    Nat Rev Drug Discov; 2013 May; 12(5):338-9. PubMed ID: 23598507
    [No Abstract]   [Full Text] [Related]  

  • 8. Garry Neil. Interview by Asher Mullard.
    Neil G
    Nat Rev Drug Discov; 2012 Nov; 11(11):826. PubMed ID: 23123934
    [No Abstract]   [Full Text] [Related]  

  • 9. Richard Bergström. Interview by Asher Mullard.
    Bergström R
    Nat Rev Drug Discov; 2011 Jun; 10(6):408. PubMed ID: 21629284
    [No Abstract]   [Full Text] [Related]  

  • 10. Stephen Frye. Interview by Asher Mullard.
    Frye S
    Nat Rev Drug Discov; 2012 Apr; 11(5):346. PubMed ID: 22495334
    [No Abstract]   [Full Text] [Related]  

  • 11. An audience with … Wolfgang Plischke.
    Plischke W; Mullard A
    Nat Rev Drug Discov; 2014 Apr; 13(4):252. PubMed ID: 24687059
    [No Abstract]   [Full Text] [Related]  

  • 12. An audience with... Gregory Lip. Interview by Asher Mullard.
    Lip G
    Nat Rev Drug Discov; 2012 Jun; 11(6):434. PubMed ID: 22653207
    [No Abstract]   [Full Text] [Related]  

  • 13. Trevor Mundel. Interview by Asher Mullard.
    Nat Rev Drug Discov; 2012 Mar; 11(4):264-5. PubMed ID: 22460116
    [No Abstract]   [Full Text] [Related]  

  • 14. An audience with... Susan Desmond-Hellmann. Interview by... Asher Mullard.
    Desmond-Hellmann S
    Nat Rev Drug Discov; 2011 Mar; 10(3):170. PubMed ID: 21358729
    [No Abstract]   [Full Text] [Related]  

  • 15. Paul Stoffels. Interview by Asher Mullard.
    Stoffels P
    Nat Rev Drug Discov; 2013 Apr; 12(4):258. PubMed ID: 23535929
    [No Abstract]   [Full Text] [Related]  

  • 16. An audience with Thomas Lönngren. Interview by Asher Mullard.
    Lönngren T
    Nat Rev Drug Discov; 2010 Dec; 9(12):912. PubMed ID: 21119726
    [No Abstract]   [Full Text] [Related]  

  • 17. Menelas Pangalos. Interview by Asher Mullard.
    Mullard A
    Nat Rev Drug Discov; 2013 Jun; 12(6):418. PubMed ID: 23722338
    [No Abstract]   [Full Text] [Related]  

  • 18. Glaxo researchers move to new home.
    Nature; 1995 Apr; 374(6525):757. PubMed ID: 7723820
    [No Abstract]   [Full Text] [Related]  

  • 19. [The miraculous growth of 'quackery funds'].
    Schuitemaker GE
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1140-1. PubMed ID: 10876712
    [No Abstract]   [Full Text] [Related]  

  • 20. . . . and funds meningitis vaccine work.
    Kenyon G
    Nat Med; 2001 Jul; 7(7):758. PubMed ID: 11433326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.